ADAMIS PHARMACEUTICALS CORP (ADMP) Stock Overview
USA - NASDAQ:ADMP - US00547W3079 - Common Stock
ADMP Key Statistics, Chart & Performance
The current stock price of ADMP is 0.7751 USD. In the past month the price decreased by -42.59%. In the past year, price decreased by -96.65%.
ADMP Latest News, Press Relases and Analysis
ADMP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 51.11 | 781.26B | ||
| JNJ | JOHNSON & JOHNSON | 18.34 | 458.55B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.76 | 258.24B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.73 | 252.36B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 13.65 | 235.32B | ||
| MRK | MERCK & CO. INC. | 11.36 | 218.53B | ||
| PFE | PFIZER INC | 7.3 | 140.77B | ||
| SNY | SANOFI-ADR | 11.73 | 125.80B | ||
| GSK | GSK PLC-SPON ADR | 9.65 | 86.97B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.51 | 89.21B | ||
| ZTS | ZOETIS INC | 23.46 | 64.68B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 50.04 | 44.25B |
Related stock screener links
About ADMP
Company Profile
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company is headquartered in San Diego, California and currently employs 11 full-time employees. Its products in the allergy, respiratory and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg, SYMJEPI (epinephrine) Injection 0.15mg and ZIMHI (naloxone HCL Injection, USP) 5 mg/0.5 mL. SYMJEPI (epinephrine) Injection 0.3mg is approved by the United States Food and Drug Administration (FDA) for use in the emergency treatment of acute allergic reactions, including anaphylaxis, for patients weighing 66 pounds or more. SYMJEPI (epinephrine) Injection 0.15mg is approved by the FDA for use in the treatment of anaphylaxis for patients weighing 33-65 pounds. ZIMHI (naloxone HCL Injection, USP) 5 mg/0.5 mL is approved by the FDA for the treatment of opioid overdose. The firm's Tempol, is an investigational drug.
Company Info
ADAMIS PHARMACEUTICALS CORP
Suite 310, 11455 El Camino Real
San Diego CALIFORNIA 92130 US
CEO: Dennis J. Carlo
Employees: 11
Phone: 18589972400.0
ADAMIS PHARMACEUTICALS CORP / ADMP FAQ
What does ADAMIS PHARMACEUTICALS CORP do?
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company is headquartered in San Diego, California and currently employs 11 full-time employees. Its products in the allergy, respiratory and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg, SYMJEPI (epinephrine) Injection 0.15mg and ZIMHI (naloxone HCL Injection, USP) 5 mg/0.5 mL. SYMJEPI (epinephrine) Injection 0.3mg is approved by the United States Food and Drug Administration (FDA) for use in the emergency treatment of acute allergic reactions, including anaphylaxis, for patients weighing 66 pounds or more. SYMJEPI (epinephrine) Injection 0.15mg is approved by the FDA for use in the treatment of anaphylaxis for patients weighing 33-65 pounds. ZIMHI (naloxone HCL Injection, USP) 5 mg/0.5 mL is approved by the FDA for the treatment of opioid overdose. The firm's Tempol, is an investigational drug.
What is the stock price of ADAMIS PHARMACEUTICALS CORP today?
The current stock price of ADMP is 0.7751 USD. The price increased by 0.86% in the last trading session.
Does ADMP stock pay dividends?
ADMP does not pay a dividend.
How is the ChartMill rating for ADAMIS PHARMACEUTICALS CORP?
ADMP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the Price/Earnings (PE) ratio of ADAMIS PHARMACEUTICALS CORP (ADMP)?
ADAMIS PHARMACEUTICALS CORP (ADMP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-11.03).
What is ADAMIS PHARMACEUTICALS CORP worth?
ADAMIS PHARMACEUTICALS CORP (ADMP) has a market capitalization of 2.16M USD. This makes ADMP a Nano Cap stock.
Can you provide the ownership details for ADMP stock?
You can find the ownership structure of ADAMIS PHARMACEUTICALS CORP (ADMP) on the Ownership tab.
ADMP Technical Analysis
ADMP Financial Highlights
Over the last trailing twelve months ADMP reported a non-GAAP Earnings per Share(EPS) of -11.03. The EPS increased by 40.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ADMP Forecast & Estimates
6 analysts have analysed ADMP and the average price target is 0.43 USD. This implies a price decrease of -44.73% is expected in the next year compared to the current price of 0.7751.